Investmed Holdings Pty Limited has acquired 25% of Presmed Australia
Advanced Health Limited has sold 25% of its shares in Presmed Australia to Investmed Holdings Pty Limited.
Presmed Australia is the owner and operator of four day hospitals in Australia. Founded in 1997, it is one of the leading healthcare companies in Australia that specializes in the establishment and management of surgical day hospitals.
Investmed Holdings is an investment company formed by the management of Presmed Australia.
Advanced Health establishes, invests in and manages day hospitals. Its facilities are modern, compact and equipped to render same-day surgical procedures.
Oaklins’ team in South Africa acted as designated advisor to Advanced Health Limited.
Talk to the deal team
Annerie Britz
Oaklins South Africa
Jean De Wet
Oaklins South Africa
Related deals
EuroHospital Varna has been acquired by Intermedica Group
EuroHospital Varna has been acquired by Intermedica Group, allowing the business to continue to grow and deliver high-quality healthcare services to its patients. Through the transaction, Intermedica Group expands its healthcare presence and intends to build a new model of integrated personalized care focused on preventive, holistic and digital medicine.
Learn moreMEDIK Hospital Design Group has been acquired by STERIS
The private shareholders of MEDIK Hospital Design Group have sold their shares to STERIS plc. Together, MEDIK and STERIS will expand their offerings for hospitals and ambulatory surgery centers worldwide. MEDIK’s solutions ideally complement STERIS’ existing portfolio, enabling the combined group to strengthen its position as a leading provider of turnkey room solutions in surgical and IPT environments. The MEDIK management team will actively support the next phase of growth.
Learn morebioXXmed AG has sold Rancoderm GmbH to Rose Investment- und Beteiligungs AG
Rancoderm GmbH has been acquired by Rose Investment- und Beteiligungs AG to secure the funding required for the final development and market approval of its medical device DermaPro. The acquisition will enable Rancoderm to bring DermaPro to market readiness and launch it as a certified medical product for broad distribution.
Learn more